We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
426
Halliburton
HAL
$27.9B
$16.8M 0.03%
684,346
+40,700
+6% +$900K
EXPD icon
427
Expeditors International
EXPD
$22.9B
$16.7M 0.03%
136,024
+27,739
+26% +$3.3M
J icon
428
Jacobs Solutions
J
$15.9B
$16.6M 0.03%
110,767
+19,398
+21% +$2.79M
IT icon
429
Gartner
IT
$9.41B
$16.6M 0.03%
62,966
+4,407
+8% +$1.29M
TECK icon
430
Teck Resources
TECK
$29.5B
$16.4M 0.03%
373,986
+20,743
+6% +$754K
ZM icon
431
Zoom
ZM
$25.8B
$16.3M 0.03%
197,834
+4,337
+2% +$338K
AMRZ
432
Amrize Ltd
AMRZ
$27.3B
$16.3M 0.03%
338,263
-260,224
-43% -$13.3M
BIIB icon
433
Biogen
BIIB
$29.9B
$16.2M 0.03%
115,706
+7,032
+6% +$951K
RBA icon
434
RB Global
RBA
$20.8B
$15.9M 0.03%
147,312
+15,595
+12% +$1.75M
LULU icon
435
lululemon athletica
LULU
$13B
$15.9M 0.03%
89,403
+5,914
+7% +$1.19M
CDW icon
436
CDW
CDW
$17.1B
$15.8M 0.03%
99,354
+882
+0.9% +$150K
STLD icon
437
Steel Dynamics
STLD
$35.6B
$15.8M 0.03%
113,273
+6,272
+6% +$823K
RKLB icon
438
Rocket Lab Corp
RKLB
$39.9B
$15.6M 0.03%
+326,311
New +$14.8M
TRMB icon
439
Trimble
TRMB
$12.3B
$15.6M 0.03%
190,714
+7,442
+4% +$607K
ZBH icon
440
Zimmer Biomet
ZBH
$17.7B
$15.5M 0.03%
157,296
+9,485
+6% +$940K
APTV icon
441
Aptiv
APTV
$12B
$15.5M 0.03%
179,484
+7,647
+4% +$577K
GDDY icon
442
GoDaddy
GDDY
$12.3B
$15.4M 0.03%
112,752
+7,079
+7% +$1.09M
WST icon
443
West Pharmaceutical
WST
$23.1B
$15.4M 0.03%
58,577
+3,012
+5% +$732K
PFG icon
444
Principal Financial Group
PFG
$23.6B
$15.3M 0.03%
185,065
+16,970
+10% +$1.36M
QSR icon
445
Restaurant Brands International
QSR
$25.1B
$15.1M 0.03%
235,047
+1,710
+0.7% +$112K
LII icon
446
Lennox International
LII
$18.8B
$15M 0.03%
28,329
+1,255
+5% +$733K
TPL icon
447
Texas Pacific Land
TPL
$28.9B
$15M 0.03%
48,093
+3,336
+7% +$1.05M
NTRA icon
448
Natera
NTRA
$37.5B
$14.9M 0.03%
92,747
+1,556
+2% +$246K
SSNC icon
449
SS&C Technologies
SSNC
$17.8B
$14.8M 0.03%
167,111
+1,628
+1% +$141K
SNA icon
450
Snap-on
SNA
$20.9B
$14.8M 0.03%
42,567
+394
+0.9% +$129K

Similar funds

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.